Pharmacokinetics and immunogenicity of eftozanermin alfa in subjects with previously-treated solid tumors or hematologic malignancies: results from a phase 1 first-in-human study.

Detalles Bibliográficos
Publicado en:	Cancer Chemotherapy & Pharmacology Vol. 93; no. 4; pp. 329 - 340
Autores principales:	Biesdorf, Carla, Guan, Xiaowen, Siddani, Satya R., Hoffman, David, Boehm, Nils, Medeiros, Bruno C., Doi, Toshihiko, de Jonge, Maja, Rasco, Drew, Menon, Rajeev M., Polepally, Akshanth R.
Formato:	Journal Article
Publicado:	Springer Nature Apr2024
Acceso en línea:	Ver este registro en EBSCOhost